Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
31/03/2026 07:00
Mar 31 (Reuters) - Allergy Therapeutics H1 gross profit GBP 21.479 million. H1 EBIT GBP -11.375 million H1 net income GBP -19.918 million
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update